Effects of Walking Exercise at a Pace With Versus Without Ischemic Leg Symptoms on Functional Performance Measures in People With Lower Extremity Peripheral Artery Disease: The LITE Randomized Clinical Trial.
functional performance
peripheral artery disease
randomized clinical trial
walking exercise
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
02 08 2022
02 08 2022
Historique:
pubmed:
28
7
2022
medline:
4
8
2022
entrez:
27
7
2022
Statut:
ppublish
Résumé
Background In people with peripheral artery disease, post hoc analyses of the LITE (Low Intensity Exercise Intervention in Peripheral Artery Disease) randomized trial were conducted to evaluate the effects of walking exercise at a pace inducing ischemic leg symptoms on walking velocity and the Short Physical Performance Battery, compared with walking exercise without ischemic leg symptoms and compared with a nonexercising control group. Methods and Results Participants with peripheral artery disease were randomized to: home-based walking exercise that induced ischemic leg symptoms; home-based walking exercise conducted without ischemic leg symptoms; or a nonexercising control group for 12 months. Outcomes were change of walking velocity over 4 m and change of the Short Physical Performance Battery (0-12, with 12=best) at 6- and 12-month follow-up. A total of 264 participants (48% women, 61% Black race) were included. Compared with walking exercise without ischemic symptoms, walking exercise that induced ischemic symptoms improved change in usual-paced walking velocity over 4 m at 6-month (0.056 m/s [95% CI, 0.019-0.094 m/s];
Identifiants
pubmed: 35894088
doi: 10.1161/JAHA.121.025063
pmc: PMC9375509
doi:
Banques de données
ClinicalTrials.gov
['NCT02538900']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e025063Subventions
Organisme : NIA NIH HHS
ID : P30 AG028740
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL122846
Pays : United States
Références
J Vasc Surg. 2005 Oct;42(4):702-9
pubmed: 16242558
Int J Cardiol. 2013 Sep 30;168(2):838-42
pubmed: 23117015
J Vasc Surg. 2020 Mar;71(3):988-1001
pubmed: 31870756
Circulation. 2017 Mar 21;135(12):e686-e725
pubmed: 27840332
Vasc Med. 2016 Apr;21(2):120-9
pubmed: 26873873
Eur J Vasc Endovasc Surg. 1997 Mar;13(3):301-5
pubmed: 9129604
J Am Coll Cardiol. 2008 Apr 15;51(15):1482-9
pubmed: 18402904
J Gerontol A Biol Sci Med Sci. 2018 Jan 16;73(2):218-224
pubmed: 28582505
J Am Coll Cardiol. 2007 Sep 4;50(10):974-82
pubmed: 17765125
Am J Phys Med Rehabil. 2005 Oct;84(10):756-62
pubmed: 16205431
J Am Geriatr Soc. 2006 May;54(5):743-9
pubmed: 16696738
J Am Coll Cardiol. 2011 Jun 7;57(23):2356-64
pubmed: 21636037
JAMA. 2021 Apr 6;325(13):1266-1276
pubmed: 33821898
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
JAMA. 2021 Jun 01;325(21):2188-2198
pubmed: 34061140
J Vasc Surg. 2000 Dec;32(6):1164-71
pubmed: 11107089
Circulation. 2012 Dec 11;126(24):2890-909
pubmed: 23159553
Int J Geriatr Psychiatry. 1998 Jun;13(6):368-80
pubmed: 9658272
Circulation. 2014 Jul 1;130(1):61-8
pubmed: 24982117
N Engl J Med. 1995 Mar 2;332(9):556-61
pubmed: 7838189